Neha Patil (Editor)

Befetupitant

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
ATC code  none
PubChem CID  6450815
Formula  C29H29F6N3O2
Molar mass  565.55 g/mol
CAS Number  290296-68-3
ChemSpider  4953365
3D model (Jmol)  Interactive image
Befetupitant httpsuploadwikimediaorgwikipediacommonsthu

Befetupitant (Ro67-5930) is a drug developed by Hoffmann-La Roche which acts as a potent and selective antagonist for the NK1 receptor. It was originally developed as a potential antiemetic drug, though development was ultimately discontinued after a related drug netupitant was deemed to be more suitable for clinical development. Befetupitant has however continued to be researched for other possible applications such as treatment of corneal neovascularization.

References

Befetupitant Wikipedia


Similar Topics
Pay the Ghost
Göta kanal 3: Kanalkungens hemlighet
Marcus Sorg
Topics
 
B
i
Link
H2
L